Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Grupo Español Multidisciplinar De Melanoma

Clinical trials sponsored by Grupo Español Multidisciplinar De Melanoma, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New combo therapy aims to tackle melanoma that resists treatment Results expected Jun 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 2 Not yet finished but already full! 2 Completed 1

New drug cocktail shows promise for rare eye cancer that spreads to liver

Disease control Completed

This study tested a combination of two drugs, sitravatinib (a pill) and tislelizumab (an IV infusion), in 16 people with a rare eye cancer (uveal melanoma) that had spread to the liver. The goal was to see if the combo could shrink liver tumors better than current treatments. Par…

Phase 2 • Sponsor: Grupo Español Multidisciplinar de Melanoma • Aim: Disease control

Last updated Jun 27, 2026 13:00 UTC